Literature DB >> 30948456

Rate of Correction of Hypernatremia and Health Outcomes in Critically Ill Patients.

Kinsuk Chauhan1, Pattharawin Pattharanitima1, Niralee Patel1, Aine Duffy2, Aparna Saha2, Kumardeep Chaudhary2, Neha Debnath1, Tielman Van Vleck2, Lili Chan1, Girish N Nadkarni3,2, Steven G Coca3.   

Abstract

BACKGROUND AND OBJECTIVES: Hypernatremia is common in hospitalized, critically ill patients. Although there are no clear guidelines on sodium correction rate for hypernatremia, some studies suggest a reduction rate not to exceed 0.5 mmol/L per hour. However, the data supporting this recommendation and the optimal rate of hypernatremia correction in hospitalized adults are unclear. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We assessed the association of hypernatremia correction rates with neurologic outcomes and mortality in critically ill patients with hypernatremia at admission and those that developed hypernatremia during hospitalization. We used data from the Medical Information Mart for Intensive Care-III and identified patients with hypernatremia (serum sodium level >155 mmol/L) on admission (n=122) and hospital-acquired (n=327). We calculated different ranges of rapid correction rates (>0.5 mmol/L per hour overall and >8, >10, and >12 mmol/L per 24 hours) and utilized logistic regression to generate adjusted odds ratios (aOR) with 95% confidence intervals (95% CIs) to examine association with outcomes.
RESULTS: We had complete data on 122 patients with severe hypernatremia on admission and 327 patients who developed hospital-acquired hypernatremia. The difference in in-hospital 30-day mortality proportion between rapid (>0.5 mmol/L per hour) and slower (≤0.5 mmol/L per hour) correction rates were not significant either in patients with hypernatremia at admission with rapid versus slow correction (25% versus 28%; P=0.80) or in patients with hospital-acquired hypernatremia with rapid versus slow correction (44% versus 40%; P=0.50). There was no difference in aOR of mortality for rapid versus slow correction in either admission (aOR, 1.3; 95% CI, 0.5 to 3.7) or hospital-acquired hypernatremia (aOR, 1.3; 95% CI, 0.8 to 2.3). Manual chart review of all suspected chronic hypernatremia patients, which included all 122 with hypernatremia at admission, 128 of the 327 hospital-acquired hypernatremia, and an additional 28 patients with ICD-9 codes for cerebral edema, seizures and/or alteration of consciousness, did not reveal a single case of cerebral edema attributable to rapid hyprnatremia correction.
CONCLUSIONS: We did not find any evidence that rapid correction of hypernatremia is associated with a higher risk for mortality, seizure, alteration of consciousness, and/or cerebral edema in critically ill adult patients with either admission or hospital-acquired hypernatremia.
Copyright © 2019 by the American Society of Nephrology.

Entities:  

Keywords:  Brain Edema; Critical Care; Critical Illness; Hospital Mortality; Hospitals; Patient Admission; Sodium; hospitalization; hypernatremia; mortality; mortality risk

Year:  2019        PMID: 30948456      PMCID: PMC6500955          DOI: 10.2215/CJN.10640918

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  20 in total

Review 1.  Hypernatremia.

Authors:  H J Adrogué; N E Madias
Journal:  N Engl J Med       Date:  2000-05-18       Impact factor: 91.245

Review 2.  Disorders of plasma sodium--causes, consequences, and correction.

Authors:  Richard H Sterns
Journal:  N Engl J Med       Date:  2015-01-01       Impact factor: 91.245

3.  Changes in brain weights during the span of human life: relation of brain weights to body heights and body weights.

Authors:  A S Dekaban
Journal:  Ann Neurol       Date:  1978-10       Impact factor: 10.422

4.  Severe hypernatremia correction rate and mortality in hospitalized patients.

Authors:  Hala M Alshayeb; Arif Showkat; Fatima Babar; Therese Mangold; Barry M Wall
Journal:  Am J Med Sci       Date:  2011-05       Impact factor: 2.378

5.  Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial.

Authors:  Samir Jaber; Catherine Paugam; Emmanuel Futier; Jean-Yves Lefrant; Sigismond Lasocki; Thomas Lescot; Julien Pottecher; Alexandre Demoule; Martine Ferrandière; Karim Asehnoune; Jean Dellamonica; Lionel Velly; Paër-Sélim Abback; Audrey de Jong; Vincent Brunot; Fouad Belafia; Antoine Roquilly; Gérald Chanques; Laurent Muller; Jean-Michel Constantin; Helena Bertet; Kada Klouche; Nicolas Molinari; Boris Jung
Journal:  Lancet       Date:  2018-06-14       Impact factor: 79.321

6.  Effects of hypernatremia on organic brain osmoles.

Authors:  Y H Lien; J I Shapiro; L Chan
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

7.  Incidence and prognosis of dysnatremias present on ICU admission.

Authors:  Georg-Christian Funk; Gregor Lindner; Wilfred Druml; Barbara Metnitz; Christoph Schwarz; Peter Bauer; Philipp G H Metnitz
Journal:  Intensive Care Med       Date:  2009-10-22       Impact factor: 17.440

8.  A clinical approach to the treatment of chronic hypernatremia.

Authors:  Ahmed Al-Absi; Elvira O Gosmanova; Barry M Wall
Journal:  Am J Kidney Dis       Date:  2012-09-06       Impact factor: 8.860

9.  Undercorrection of hypernatremia is frequent and associated with mortality.

Authors:  Stanislas Bataille; Camille Baralla; Dominique Torro; Christophe Buffat; Yvon Berland; Marc Alazia; Anderson Loundou; Pierre Michelet; Henri Vacher-Coponat
Journal:  BMC Nephrol       Date:  2014-02-21       Impact factor: 2.388

10.  MIMIC-III, a freely accessible critical care database.

Authors:  Alistair E W Johnson; Tom J Pollard; Lu Shen; Li-Wei H Lehman; Mengling Feng; Mohammad Ghassemi; Benjamin Moody; Peter Szolovits; Leo Anthony Celi; Roger G Mark
Journal:  Sci Data       Date:  2016-05-24       Impact factor: 6.444

View more
  12 in total

1.  Understanding the renal response to brain injury.

Authors:  Matthieu Legrand; Romain Sonneville
Journal:  Intensive Care Med       Date:  2019-07-11       Impact factor: 17.440

2.  Evidence for Managing Hypernatremia: Is It Just Hyponatremia in Reverse?

Authors:  Richard H Sterns
Journal:  Clin J Am Soc Nephrol       Date:  2019-04-04       Impact factor: 8.237

Review 3.  Hyponatraemia and hypernatraemia: Disorders of Water Balance in Neurosurgery.

Authors:  Mendel Castle-Kirszbaum; Mervyn Kyi; Christopher Wright; Tony Goldschlager; R Andrew Danks; W Geoffrey Parkin
Journal:  Neurosurg Rev       Date:  2021-01-03       Impact factor: 3.042

Review 4.  Improving on the Adrogué-Madias Formula.

Authors:  Sheldon Chen; Michael Shieh; Robert Chiaramonte; Jason Shey
Journal:  Kidney360       Date:  2020-12-04

5.  Outcomes Associated with Hypernatremia at Admission in Hospitalized Persons.

Authors:  Bryan M Tucker; Carl P Walther
Journal:  Kidney360       Date:  2022-07-28

6.  Serum sodium trajectory during AKI and mortality risk.

Authors:  Jonathan S Chávez-Íñiguez; Pablo Maggiani-Aguilera; Helbert Rondon-Berrios; Kianoush B Kashani; Christian Pérez-Flores; Jorge Michel-González; Andres E De la Torre-Quiroga; Andrea Luna-Ramos; Guillermo Navarro-Blackaller; Alexia Romero-Muñoz; Ana T Martínez-Navarro; Gael Chávez-Alonso; Ramón Medina-González; Guillermo García-García
Journal:  J Nephrol       Date:  2022-01-21       Impact factor: 3.902

7.  Association Between ICU-Acquired Hypernatremia and In-Hospital Mortality: Data From the Medical Information Mart for Intensive Care III and the Electronic ICU Collaborative Research Database.

Authors:  Markus Harboe Olsen; Marcus Møller; Stefano Romano; Jonas Andersson; Eric Mlodzinski; Nathan H Raines; Raphael Sherak; Anni Nørgaard Jeppesen
Journal:  Crit Care Explor       Date:  2020-12-16

8.  Progression to Severe Hypernatremia in Hospitalized General Medicine Inpatients: An Observational Study of Hospital-Acquired Hypernatremia.

Authors:  Ramessh Ranjan; Stacey C-Y Lo; Stephanie Ly; Visakan Krishnananthan; Andy K H Lim
Journal:  Medicina (Kaunas)       Date:  2020-07-17       Impact factor: 2.430

9.  The Effect of Fibrates on Kidney Function and Chronic Kidney Disease Progression: A Systematic Review and Meta-Analysis of Randomised Studies.

Authors:  Alexandros Hadjivasilis; Panayiotis Kouis; Andreas Kousios; Andrie Panayiotou
Journal:  J Clin Med       Date:  2022-01-31       Impact factor: 4.241

10.  The Corrected Serum Sodium Concentration in Hyperglycemic Crises: Computation and Clinical Applications.

Authors:  Todd S Ing; Kavitha Ganta; Gautam Bhave; Susie Q Lew; Emmanuel I Agaba; Christos Argyropoulos; Antonios H Tzamaloukas
Journal:  Front Med (Lausanne)       Date:  2020-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.